Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
+2.51 (1.81%)
After Hours: 141.19 0.00 (0.00%)
Oct 8, 4:36PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 137.70 - 141.34
52 week 109.34 - 149.95
Open 138.56
Vol / Avg. 597,896.00/443,854.00
Mkt cap 11.57B
P/E 25.56
Div/yield     -
EPS 5.52
Shares 83.40M
Beta 0.98
Inst. own 98%
Nov 4, 2015
Q3 2015 Henry Schein Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Sep 16, 2015
Henry Schein Inc at Morgan Stanley Healthcare Conference
Sep 9, 2015
Henry Schein Inc at Wells Fargo Healthcare Conference
Sep 9, 2015
Henry Schein Inc at Robert W Baird and Co Health Care Conference
Jul 29, 2015
Q2 2015 Henry Schein Inc Earnings Call - Webcast
Jul 29, 2015
Q2 2015 Henry Schein Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 4.79% 4.76%
Operating margin 6.96% 6.90%
EBITD margin - 8.31%
Return on average assets 8.39% 8.39%
Return on average equity 16.90% 16.65%
Employees 17,500 -
CDP Score - -


135 Duryea Rd
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Company's global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 58
Bio & Compensation  - Reuters
James P. Breslawski CPA President, Henry Schein and Chief Executive Officer, Global Dental Group, Director
Age: 61
Bio & Compensation  - Reuters
David C. McKinley President, Medical Group
Age: 62
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group
Age: 56
Bio & Compensation  - Reuters
Lonnie Shoff Chief Executive Officer of Global Animal Health and Strategic Partnership Group
Age: 56
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Harding Chief Technology Officer, Senior Vice President
Age: 59
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance